États-Unis · Bourse & Finance · The Motley Fool

Why Viking Therapeutics needs the cash

Publié par The Motley Fool · États-Unis il y a 8 h

Viking Therapeutics raised $575 million to fund major obesity drug trials, develop its pipeline, and support commercial development of any approvals for VK2735.

Lire l'article complet sur The Motley Fool Connectez-vous pour sauvegarder

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.fool.com)

Why Viking Therapeutics needs the cash

À lire aussi

Meta says it shut down No Kings Instagram account because it thought bots had been unleashed

Anthropic commits 5% of its stock to a new ‘public benefit’ fund and may give large donations to traditional nonprofits or to specific populations

SEC tokenized stock framework faces issuer pushback as Broadcom, Verizon object to OKX-ICE listing

10 things first-time cruisers wish they knew before boarding

India’s Finance Minister blames easy exits and excess liquidity for equity market's underperformance

Record Shipping Costs Force Oil Producers to Slash Prices

Why Viking Therapeutics needs the cash

Partager

À lire aussi

Meta says it shut down No Kings Instagram account because it thought bots had been unleashed

Anthropic commits 5% of its stock to a new ‘public benefit’ fund and may give large donations to traditional nonprofits or to specific populations

SEC tokenized stock framework faces issuer pushback as Broadcom, Verizon object to OKX-ICE listing

10 things first-time cruisers wish they knew before boarding

India’s Finance Minister blames easy exits and excess liquidity for equity market's underperformance

Record Shipping Costs Force Oil Producers to Slash Prices